Roxana Mehran, MD

Dr Mehran is a recipient of several awards including the 2016 American College of Cardiology Bernadine Healy Leadership in CV disease award, the 2018 Nanette Wenger Award from Women’s Heart for excellence in research and education, the 2019 Ellis Island Medal of Honor, and the 2019 ESC Silver Medal and Andreas Grüntzig Lecture plaque. She was recently awarded the Terry Ann Krulwich Physician-Scientist Alumni Award at Mount Sinai, for excellence in science and medicine, and the Linda Joy Pollin Heart Health Leadership Award, as well as the Doctor Honoris Causa Degree at Università della Svizzera Italiana (2022).

She has built a globally respected academic research center focused on developing randomized clinical trials and has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, participates regularly in developing clinical guidelines, and has authored >1300 peer-reviewed articles. Dr. Mehran is a current member of the American College of Cardiology (ACC) Board of Trustees. She has been included for six consecutive years in the Clarivate Analytics Most Cited Researchers – Top 1% list as well as the Thomson Reuters list of The World’s Most Influential Scientific Minds.

Dr. Mehran is currently leading the Lancet Commission on Women’s Cardiovascular Diseases, which brings together leading female researchers from around the world to identify and bridge gaps in research and care for women with cardiovascular disease. She was recently named Director of the Women Heart and Vascular Center at Mount Sinai Heart, spearheading a new program that represents a collaboration across multiple disciplines and is designed to meet the unique needs of women’s cardiovascular health. In 2019, she founded Women as One, dedicated to advancing opportunities for women in medicine.